All Activity

We’ve created a “spontaneous discount” for bookings made within the next hour. Our Call Girls Near The Acura Bmk Hotel Gurugram rewards impulsiveness. Desire struck? Don’t overthink it. Book now, save money, and have a companion at your door before you change your mind.

This particular is usually apparently essential and moreover outstanding truth along with for sure fair-minded and moreover admittedly useful My business is looking to find in advance designed for this specific useful stuffs… koitoto

Very efficiently written information. It will be beneficial to anybody who utilizes it, including me. Keep up the good work. For sure i will check out more posts. This site seems to get a good amount of visitors. แทงบอล

It’s inspiring to see someone like Chiara Juster dedicating so much time and expertise to advocating for plant medicine and supporting the community. Her legal work sounds incredibly impactful, especially in such a rapidly evolving space. Stories like this remind me how important it is to build supportive networks—kind of like how communities such as Football Bros bring people together around shared passions.

The idea thinks wonderful you just read this sort of helpful along with exclusive content on the internet sites. Mystic Fortune Deluxe Certainly great, remarkable, fact-filled tips these. Ones own content articles Be required to fail, thinking that obviously is true these on top of that. One normally generate an intriguing browse. On earth do you enlighten So i'm shocked?: )#) Compete the great articles and reviews. bandar bola It again has the opinion fantastic to study many of these instructive not to mention specific content pieces within your ınternet sites. situs slot Pleasant write-up, it is an incredibly trendy blog site that you've got in this article, sustain the favorable do the job, will likely be returning. agen bola Pleasant write-up, it is an incredibly trendy blog site that you've got in this article, sustain the favorable do the job, will likely be returning. slot online

“We are doing our best to create the right regulatory scheme to be able to adequately enforce the market.” By Ben Solis, Michigan Advance The Michigan Senate is refocusing its marijuana industry license cap legislation to include new barriers to obtaining a license for growers, processors or dispensary operators with outstanding industry-related tax debt—a move that would help shore up the industry as it deals with a new 24 percent wholesale tax. The Michigan Senate Regulatory Affairs Committee on Wednesday heard a second round of testimony on recent changes to Senate Bill 597, a bill proposing new caps on state marijuana industry licenses. The hearing comes nearly a year after the bill was introduced and was the subject of a first hearing in October 2025. Sponsored by Sen. Sam Singh (D-East Lansing), SB 597 would cap licenses for marijuana retailers and wholesalers to one license per 10,000 residents in a municipality beginning January 1, 2026. The move would be similar to how the state regulates liquor sales, Singh said last year. SB 597 is also part of a larger package. Senate Bills 599–602 aim to create a regulatory framework for consumable hemp products in Michigan. That portion was mainly sponsored by Sen. Dayna Polehanki (D-Livonia), and was introduced as a way to regulate intoxicating products made from hemp, including Delta-8 and other synthesized cannabinoids, which are sold in Michigan gas stations, convenience stores and online marketplaces. Those pieces were advanced out of the Democratic-controlled Senate late last year, and now sit in the GOP-led House. The license cap piece is still being worked out by the Senate. Singh’s testimony on Wednesday served to refresh the committee’s memory on the legislation, and to go over the details of the newly adopted language of the bill. One of the biggest changes requires licensees to have paid all state taxes when seeking another license. That would require a potential licensee to pay back the base tax owed, fees and tax penalties. Singh said the change would align the marijuana industry with the way liquor licenses are controlled and regulated in Michigan. The senator said that one issue currently facing the Cannabis Regulatory Agency is that it has no ability to deny an applicant for a new license if that applicant held a previous license, but closed it while still owing various state industry taxes, including a required excise tax. Under the current regulatory framework, a licensee could potentially close their existing license and that tax debt wouldn’t follow them as they seek a new license—with the CRA lacking a mechanism to halt that process due to the outstanding tax owed. Singh said that was more important than ever considering how the Legislature added a new 24 percent wholesale tax into its 2025-26 budget deal. The Legislature implemented the tax with an estimated $420 million annually for road funding. The industry is currently fighting that tax in court, as its stakeholders argue the tax will generate less revenue than projected from the wholesale marijuana tax. Recent reporting indicates the industry’s struggles have been further exacerbated with tax revenues falling short of expectations, according to The Gander. “Now that we have a 24 percent wholesale tax, I could see this becoming more and more of an issue,” Singh said. “If we want to make sure that that is a stable revenue, which again, we might be a little bit low on that revenue to begin with, we need to make sure that these protections are there.” The updated language has a provision to put a moratorium on new grower licenses, but allows current growers to build out and get an additional license to expand. Singh said this was also done for market stabilization. Another change addresses product returns. “We heard from the wholesale community that currently, right now, within law, there is not a policy on how you return product,” Singh said. “What we’ve been hearing from wholesalers is that some people are returning product weeks upon weeks, and even months, after they have received it. So they’ve asked us to find a way to sort of deal with the return product. What our bill basically does is that you have up to three days to return the product, and it has to be in its original wrappings and original containers.” The committee did not take further action on the bill. Following the hearing, Michigan Advance asked Singh if the changes were an admittance that the state’s new wholesale tax wasn’t creating the kind of revenue the Senate and House had hoped for. Singh said it was not a reaction to the ongoing issues with the tax. “We’ve been working on this, these sets of issues, since April of last year. When you have an initiative that is passed by the voters, there’s oftentimes things that they never thought about, especially on the regulatory side, the enforcement side,” Singh said. “We are doing our best to create the right regulatory scheme to be able to adequately enforce the market, ensure that the product is safe for those who are going to use the product, but at the same time make sure that everyone’s paying their taxes.” As to whether the bill would help make sure more licensees are paying the appropriate tax, Singh said the Legislature, the state and its marijuana industry counterparts will have to wait and see. “I always share my personal concerns that that tax was probably higher than it should have been. I think there could have been a combination, an increase on the retail side with the excise tax, and then maybe a smaller wholesale tax,” Singh said. “But at this point in time, I think it’s premature to gauge where we’re going to be at. I think after a couple more quarters, we’ll get a strong sense of what that revenue is going to look like as we go forward.” This story was first published by Michigan Advance. The post Michigan Lawmakers Take Up Bill To Cap Marijuana Business Licenses As Industry Reels From Tax Increase appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“On Illinois dispensary shelves, a crowd of brands hides a shrinking set of owners, and the state’s rules are speeding the squeeze.” By Hedy Yang, Parabola Center for Law and Policy Illinois built its adult-use cannabis market on a promise of equity and opportunity. Six years in, 264 brands compete on dispensary shelves across the state. But those brands answer to far fewer owners, and a few incumbents capture nearly 79 cents of every dollar in statewide revenue. For a new report, Parabola Center analyzed 16 quarters of Headset retail data (2022–2025), mapping every active brand in Illinois to the company that controls it. Where ownership was ambiguous, we credited the smaller operator, so if anything these figures understate concentration. Specific policy choices produced this concentration. Illinois engineered the conditions, and the market followed. When adult-use sales began in 2020, only Illinois’s existing medical cultivation centers could supply the market. Craft growers faced years of administrative delays, handing incumbents a roughly two-year head start that hardened into a lasting advantage. The market only looks like it’s diversifying. The number of active brands has climbed steadily, but those brands belong to fewer and fewer owners. Active parent companies peaked at 91 in early 2025 and fell to 79 by year’s end. This is the “illusion of choice” that runs through many U.S. consumer markets, alcohol included. What looks like a wave of independent brands is mostly incumbents extending their reach, their interests aligned rather than opposed. In Q4 2025, MSOs (multi-state operators, vertically integrated firms spanning cultivation, processing, and retail) sold 42 percent of units while capturing 69 percent of statewide revenue. Independent operators (Illinois craft growers and small brands) sold 27 percent of units but took in only 8.1 percent of revenue. This gap is structural, written into the licensing rules. Illinois offers no standalone extraction license. The right to turn raw cannabis into concentrate belongs to the state’s incumbent cultivation centers and to craft growers, whose canopy is capped at 14,000 square feet against the 210,000 a cultivation center can run. Infusers, the one manufacturing license open to most newcomers, cannot extract at all and must buy concentrate from the same incumbents they compete with. That is how edibles, concentrates, and cartridges end up controlled at the source. Of 89 craft grower licenses issued, only 21 are operating. Together, at their legal maximum, those 21 are permitted less canopy than one and a half cultivation centers. The same imbalance shapes the flower market. Wholesale flower is a commodity, and prices have fallen nearly 40 percent since 2022. MSOs absorb this drop through their margins on concentrates and vapes. Independents are left effectively locked into flower. And it may get worse. Concentration is rising again. The Herfindahl-Hirschman Index, the standard measure of market concentration, fell year over year for 10 straight quarters. It hit its low in late 2024 and has since risen, posting its first year-over-year increase in Q3 2025. The four largest companies controlled 45 percent of the market at that low point; a year later they controlled 47 percent. Q4 2025 was the first quarter on record with more brands leaving than entering. Some of this is an ordinary shakeout after oversupply. But the pain need not fall so unevenly. It does because independents are penned into flower, the category that oversupply hit hardest, while license rules block any move elsewhere. The retail figures understate the problem. The real chokepoint sits in cultivation and extraction capacity, controlled by a few incumbents and invisible in any brand count. Parabola’s findings echo the state’s own Adult-Use Cannabis Industry Disparity Study from July 2024. The state promoted the study as proof Illinois has the most diverse cannabis industry in the country, and on license ownership, that may have been true at the time. Minority- and women-owned businesses hold most dispensary, craft grower and infuser licenses. But owning a license is not the same as capturing value. The same study found minority- and women-owned dispensaries earned just 12.5 percent of revenue while holding 59 percent of licenses. It flagged thin financing for equity businesses and weak data collection, and it urged the state to consolidate its fragmented oversight. This corporate takeover was not inevitable. Lawmakers built it one choice at a time, each tilting toward the largest operators, which means the same lawmakers can level the field. Our report lays out how. The state must do three things. First, create a standalone extraction license and lift the canopy cap on craft growers, so independents can make high-margin concentrates and vapes instead of buying them from competitors. Second, consolidate regulatory oversight into a single agency, so fragmented authority stops favoring large incumbents. Third, mandate parent-company disclosure on product labels, so brand diversity can no longer hide ownership. Consumers and independent operators have already paid for Illinois’s years of inaction. With these steps, Illinois can reverse course and finally build the diverse, competitive market its own equity goals were always meant to deliver. Hedy Yang is an Economic Research Fellow at Parabola Center for Law and Policy, where she researches corporate concentration in cannabis markets. She has previously studied antitrust policy and corporate power at the American Economic Liberties Project. The post How Illinois Marijuana Rules Built A Marketplace Controlled By A Few, Despite Promises Of Equity And Opportunity (Op-Ed) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

An organization that represents the restaurant industry is calling on Congress to delay the federal recriminalization of hemp THC beverages that is scheduled to take effect later this year and replace it with a regulatory framework that “ensures consumer safety while meeting growing market demand” for the products as an alternative to alcohol. The National Restaurant Association sent a letter to leadership in the Senate and House of Representatives outlining its support for keeping hemp THC beverages legal with “durable” federal regulations that include age verification, quality control, labeling requirements and impairment standards while also allowing states and localities to set tailored rules for their markets—”similar to that of alcoholic beverages.” Sean Kennedy, chief advocacy officer for the organization, said in a press release that “consumers have made it clear that they want hemp-derived THC beverages.” “The only question is whether Washington will create a way they can enjoy them safely or if they will allow a thriving market supporting small business owners to disappear because they wouldn’t create a sensible regulatory framework,” he said. The restaurant association cited internal research showing that 5 percent of restaurants that serve alcohol currently also offer hemp drinks, and that 26 percent of all restaurants are interested in offering them under a regulatory framework, which it said represents a potential market of $1.6 billion annually. “Consumer demand for THC beverages is driven by a shift in drinking habits, particularly among younger diners whose lifestyles are diverging from traditional beverage alcohol,” Kennedy said. “For operators—especially those running high-volume beverage venues—these products offer an alternative for guests who want a social drinking experience without alcohol.” The restaurant group is asking Congress to delay the ban for two years, which it says would “provide the predictability operators need, particularly multi-unit and franchised brands navigating varied state approaches, while the existing state-regulated market for low-dose products continues and Congress develops a national framework.” “The restaurant industry’s highest priority is the safety of our customers, and our workforce is well-positioned to serve these products responsibly,” the letter to the top Democratic and Republican leaders of the House and Senate says. “Operators selling alcohol beverages have established training and impairment management practices that could be adapted for serving hemp-derived THC beverages.” “For many operators, particularly high-volume beverage venues, these products serve as alcohol alternatives for guests wanting to participate in social settings. For consumers whose lifestyles are diverging from traditional beverage alcohol preferences, restaurants want the ability to meet that demand in a safe and regulated market.” Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that President Donald Trump signed during his first term in office. But late last year, he signed new legislation containing provisions that will redefine hemp to make it so only products with 0.4 milligrams of total THC per container will remain legal after November 12. “Time is short,” Kennedy said. “We urge Congress to act now: delay implementation and commit to the deliberate, safety-focused regulatory process which this emerging market deserves.” As Marijuana Moment reported earlier this week, a Republican congresswoman is circulating draft legislation that would keep hemp THC beverages legal under federal law, creating a carve-out from the broad recriminalization of products derived from the crop that is set to take effect later this year. The Hemp-Derived Beverage Regulatory Clarity Act from Rep. Beth Van Duyne (R-TX), in its current form, would allow adults over 21 to purchase and consume hemp THC drinks with up to 5 milligrams of delta-9 THC per serving. It would also impose a federal tax of 10 cents per milligram of any hemp-derived cannabinoid contained within such beverages. The circulation of the new draft legislation and the restaurant group’s push comes as the White House is separately making it clear that Trump wants Congress to take action to amend the law that threatens to federally recriminalize hemp-derived products. The administration “welcomes the opportunity to work with the Congress to, at a minimum, update the statutory definition of final hemp-derived cannabinoid products to allow Americans to benefit from access to appropriate full-spectrum CBD products,” the Office of Management and Budget (OMB) said this month, “while preserving the Congress’s intent to restrict the sale of products that pose serious health risks.” The call to avert a broad prohibition on hemp CBD products was included in a statement of administration policy about an annual agriculture spending bill that passed the House of Representatives. Several lawmakers had filed amendments to that legislation to keep hemp products legal, but each was either blocked by the House Rules Committee from advancing to a floor vote or withdrawn by its sponsor. “The Administration supports advancement of this legislation, but looks forward to addressing its concerns prior to enactment,” OMB said in its statement of administration policy. “The Administration looks forward to working with the Congress to provide more input as the bill’s legislative process unfolds.” In April, the president himself urged congressional lawmakers to again redefine hemp to avoid recriminalization of full-spectrum CBD products. “I am calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on, and that help them, while preserving Congress’s intent to restrict the sale of products that pose Health risks,” Trump said in a Truth Social post on the same day his administration announced it is moving forward with rescheduling marijuana. “We must get this done RIGHT and FAST, especially for those who saw that CBD helps them,” he said. “Plus, I am told it will also help our GREAT FARMERS, who we love, and will always be there for.” Industry advocates say that the law as enacted last year not only threatens to prohibit intoxicating and synthetic cannabinoid products but also stands to remove popular full-spectrum CBD products that many Americans use therapeutically from the market. “ONE in FIVE adults used it in the past year, and many say it improved their chronic pain enormously,” the president said in his social media post, adding that hemp-derived CBD “has made a HUGE difference for so many people.” He also referenced a new initiative the administration launched in April to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. The program being implemented by the Centers for Medicare & Medicaid Services (CMS) focuses largely on CBD but also allows products to have up to 3 milligrams of total THC per serving. “In December, I signed a very important Executive Order calling for Research and Innovation for Hemp-derived CBD,” Trump said. “Our wonderful Dr. Mehmet Oz moved fast to follow the directive in the Executive Order, and launched a model for some Seniors earlier this month. But more must be done!” “Please get it done, and SOON,” the president said in reference to a congressional fix for the broad recriminalization set to take effect in November. “Thank you for your attention to this matter!” It’s not clear how far Trump wants to scale back the scope of the scheduled federal restrictions on hemp products and what kinds of revised THC rules and limitations he would prefer to sign into law. Separately, White House officials recently provided a congressman’s office with feedback on hemp regulatory legislation. In April, Vince Haley, director of the White House Domestic Policy Council and James Braid, assistant to the president for legislative affairs, sent hemp policy suggestions to Rep. Andy Barr (R-KY). “We appreciate your work to advance the policy of” an executive order Trump signed in December that included provisions seeking to protect Americans’ access to CBD products, the staffers wrote in a letter to the congressman. “We are transmitting for your consideration draft legislative text and comments to address the statutory definition of final hemp-derived cannabinoid products in order to allow Americans to benefit from access to appropriate full-spectrum CBD products while preserving the Congress’s intent to restrict the sale of products that pose serious health risks,” the White House officials said, according to a social media post containing a screenshot of the letter. “We are available for discussion and further technical assistance.” Separately, anti-marijuana organizations filed a lawsuit suit against the Medicare hemp CBD coverage policy—but a judge dismissed the case last month, ruling that they don’t have standing. Lawyers for Health and Human Services Sec. Robert F. Kennedy Jr. and CMS Director Mehmet Oz had filed a brief asking that the case be dismissed. The White House Office of Management and Budget has also held a series of meetings about a Food and Drug Administration (FDA) CBD products enforcement policy. FDA issued guidance making clear that it does not intend to interfere with implementation of the Medicare hemp-derived products coverage plan. CMS separately finalized a rule that will allow coverage of some hemp products as specialized, non-primarily health-related benefits through Medicare Advantage plans. As hemp products have become more popular with consumers, some large brands are attempting to get in on action. Major retailer Target, for example, is expanding its participation in the hemp-derived THC beverage market. Last year, the company began a pilot program involving sales of cannabis drinks at 10 select stores in Minnesota. That apparently went well, and now the company has obtained licenses from Minnesota regulators to sell lower-potency hemp edible products—including THC drinks—at all 72 of its stores in the state. A U.S. Department of Agriculture report published in April shows that farmers in the U.S. grew three-quarters of a billion dollars worth of hemp crops in 2025—a 64 percent increase from the prior year. The post Major Restaurant Lobby Group Pushes Congress To Keep Hemp THC Drinks Legal As An Alternative To Alcohol appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Legalizing medical marijuana appears to be associated with reduced rates of employees missing work—particularly in trades like manufacturing and agriculture where workers are more likely to experience symptoms such as pain that cannabis can help treat—according to a new study. Researchers at the University of Southern Maine and University of Georgia looked at the potential impact of state-level marijuana reform on workplace absenteeism, analyzing federal data from the U.S. Census Bureau and Bureau of Labor Statistics from 1990 to 2025. The study, published in the Journal of Workplace Behavioral Health, found that, overall, legalizing medical cannabis is linked to a 6.9 percent decrease in rates of employees calling out of work due to illness, injury or other medical issues. Notably, the study—which involved a total dataset covering more than 20 million workers between the ages of 18 and 61—assessed the relationship between cannabis policy and workplace absenteeism for different types of work and industries. “The absenteeism-reducing effects of medical cannabis decriminalization are concentrated in occupations and industries in which chronic pain, physical strain, and job-related stress are plausibly important determinants of missed work,” the study said. “Medical cannabis laws appear to reduce sickness absence in settings where therapeutic use is likely to be most relevant.” “This study identifies a statistically significant and quantitatively meaningful effect of medical cannabis laws in the United States on reducing health-related workplace absenteeism.” It found the manual laborers missed work 39 percent less, followed by reduced absenteeism from industrial machine operators (33 percent), health-service workers (32 percent), farm workers (18 percent), food preparation employees (10 percent) and construction workers (10 percent). The industry-by-industry analysis linked medical cannabis legalization to 31 percent fewer sick or injured days in the durable goods manufacturing sector and 16 percent for nondurable goods manufacturing. Absenteeism decreased on average 16 percent for the agriculture industry, 9 percent for construction and 8 percent for business services. “The most substantial reductions” were “observed in occupations and industries that involve physical demands and repetitive strains of work,” the study authors said. “Our results are consistent with a therapeutic channel through which medical cannabis access improves symptom management and reduces sickness absence.” Aside from medical cannabis policies, study found “no significant effect of recreational cannabis legalization on health-related workplace absenteeism.” “Although the estimated effect of recreational cannabis decriminalization was positive, it was not measured with sufficient precision to achieve statistical significance,” it said. Meanwhile, research published last year on marijuana legalization’s effect on workers’ compensation found that while the policy change was associated with a “gradual increase” in workers’ comp claims, the average cost per claim in fact fell after the policy change—as did patient use of prescription drugs, especially opioids and other painkillers. In 2021, a separate study by the National Bureau of Economic Research found that adult-use cannabis legalization was associated with an increase in workforce productivity and decrease in workplace injuries. Those researchers looked at the impact of recreational cannabis legalization on workers’ compensation claims among older adults, observing declines in such filings “both in terms of the propensity to receive benefits and benefit amount” in states that have enacted the policy change. They further identified “complementary declines in non-traumatic workplace injury rates and the incidence of work-limiting disabilities” in legal states. “We offer evidence that the primary driver of these reductions [in workers’ compensation] is an improvement in work capacity, likely due to access to an additional form of pain management therapy,” says the earlier study, which received funding from the National Institute on Drug Abuse (NIDA). A 2020 study, meanwhile, found that legalizing medical marijuana led to fewer and cheaper workers’ compensation claims. Researchers from the University of Cincinnati Ash Blue College and Temple University concluded that permitting medical cannabis “can allow workers to better manage symptoms associated with workplace injuries and illnesses and, in turn, reduce need for [workers’ compensation].” Earlier this month, a congressional committee approved a bill containing a provision to block federal workers’ compensation programs from covering medical marijuana—even in light of the Trump administration’s move to reschedule cannabis. In 2022, the U.S. Supreme Court declined to take up a pair of cases concerning workers’ compensation for medical marijuana. Other research from 2023 into employee marijuana use found that workers who used the drug off the clock were no more likely to experience workplace injuries compared to those who didn’t consume cannabis at all. However, people who indulged during work hours are nearly twice as likely to be involved in a workplace incident than both non-users and off-duty users. Separately, a 2024 analysis of five years’ worth of federal health survey data by researchers at the Centers for Disease Control and Prevention (CDC) found that employees in the food service and hospitality industries were some of the most common consumers of marijuana among U.S. workers. People in arts, design, entertainment, sports and media occupations also reported comparatively high rates of past-month cannabis use, as did workers in construction and extraction. Among those least likely to report marijuana use, meanwhile, were law enforcement, health care providers and workers in libraries and education. The post Fewer Employees Skip Work Days Where Medical Marijuana Is Legal, Especially For Manual Labor Jobs, Study Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I’m encouraged while using surpassing along with preachy list that you just adorn such minor timing. Google Ads Agency London

this can be awesome plus meanful. this can be interesting site. Leading is rather handy element. you may have seriously made it simpler for many people who seem to take a look at site and give these folks usefull information and facts. Google Ads Agency London

The two South Carolina Republican candidates in a runoff election for their party’s nomination to serve as the state’s next governor say they are open to signing legislation to legalize medical marijuana if elected to the job. The moderator of a debate on Tuesday noted that “even ruby red states” are moving to allow medical cannabis use, pressing both contenders on whether they believe there is a pathway for it to be legalized in South Carolina. Pamela Evette, currently the state’s lieutenant governor, said her father died a “horrible death” from lung cancer and that “if I could have given him something that would have eased his pain in the last few days of his life, I would have done it.” “If the General Assembly can bring me, as governor, a piece of legislation that doesn’t end up being an open door to recreational use, I would heavily sit down and look at that,” she said. “But I would bring in experts and doctors to make sure that we can tighten that to really just help people who medically need it, people who have tried everything and people who are sitting in the last minutes of their life—because nobody should have to watch their loved one die in pain,” Evette said. She also noted that she and incumbent Gov. Henry McMaster (R) have already worked “very close” with law enforcement on the issue—though comprehensive medical cannabis legislation has never reached the governor’s desk in South Carolina. Alan Wilson, who currently serves as state attorney general, said during Tuesday’s debate that he “would be open to on the medical side. ” “I have always taken the position and agree with what the Trump administration did,” he said. “The Trump administration called for the rescheduling of marijuana from a Schedule I to a Schedule III. What that means is it can be studied for medical application, which it couldn’t, as a Schedule I drug.” “I have met with so many veterans who are suffering from PTSD, people that I’ve actually served with in Iraq. I have met with people suffering with seizures, people suffering with chronic illness, people suffering, people who are terminal,” Wilson said. “And if there is a possibility that we could derive some use from the medical application of that, then South Carolina should follow suit with what the federal government is doing, and have clearly defined laws and regulations that prevent it from being abused. I would be open to the medical use of it.” Like Evette, the attorney general noted, however, that he does not support legalizing marijuana for recreational use. “Obviously, I’ve spoken with law enforcement leaders all over the country, as well as elected leaders, both in the Republican and Democratic parties, who have told me, ‘whatever you do, do not have recreational marijuana,'” he said. “They can’t say that publicly in their home states, but they said it has been an absolute disaster.” The primary runoff election between the two candidates is on Tuesday. Democratic gubernatorial nominee Jermaine Johnson, currently a state representative, says on his campaign website that “it’s time for South Carolina to make medicinal marijuana safe, legal, and accessible.” “This means more jobs and income for farmers, a state wide tax on cannabis that will allow us to balance the budget, and medical freedom for people who are suffering,” it says. “Additionally, Jermaine will commute the sentence of all prisoners who have non-violent marijuana related charges. This will relieve the burden on our state’s prison system and restore families who have been destroyed by punitive and antiquated drug policies.” The campaign also says Johnson would seek to “put recreational cannabis to a state-wide referendum.” We need a smarter approach to marijuana policy. Legalize medical use. Pardon non-violent charges. Let the people decide recreational use through a statewide referendum. Compassion. Fairness. Accountability.https://t.co/gWBw9vMJ3w pic.twitter.com/7A9n4reVSS — Jermaine Johnson (@Dr_JLJohnson) April 20, 2026 Republican candidates for South Carolina attorney general recently clashed on medical cannabis and hemp issues during a debate. Meanwhile, a Republican South Carolina state senator said that “medical marijuana is now legal” in the state following the Trump administration’s move to enact federal rescheduling. State Sen. Tom Davis (R), who has sponsored bills to legalize medical cannabis over a number of sessions, said that under a little-known state law he believes was triggered by federal rescheduling, “we have just become the 41st state that has a legally authorized medical marijuana program.” State statute says that “if a substance is added, deleted, or rescheduled as a controlled substance pursuant to federal law or regulation,” officials then have 30 days to reschedule the drug in the “appropriate schedule” under state law. A separate law, the South Carolina Controlled Substances Therapeutic Research Act, passed in 1980, sets up a program through which certain patients could obtain medical cannabis “through whatever means” the state health commissioner “deems most appropriate consistent with federal law.” The governor’s office confirmed to local media that South Carolina law will “require the State to mirror the new federal order” on marijuana rescheduling. And the South Carolina Department of Public Health (DPH) said that officials are “aware of the proposed rescheduling of medical marijuana from Schedule I to Schedule III under the Controlled Substances Act” and are “assessing the impacts to DPH and the state of South Carolina.” Last year, South Carolina’s governor said there’s a “compelling” case to be made for legalizing medical marijuana in the state, despite reservations from law enforcement. “I think what we need to do is study it very carefully, get as much information as we can and try to do the right thing,” he said. The office of House Speaker Murrell Smith (R) tempered expectations, however, referencing what he viewed as insufficient support within the GOP caucus to advance the reform through his chamber. An earlier version of Davis’s cannabis measure passed the Senate in the 2024 session but was never taken up in the House. He filed a new version for the 2025 session, but it did not advance. “It requires doctors in patient authorization, doctor supervision,” Davis said at the time. “It requires pharmacists to dispense it. It is a very conservative bill, because that’s what South Carolinians want.” As introduced, the legislation would allow patients to access medical marijuana from “therapeutic cannabis pharmacies,” which would be licensed by the state Board of Pharmacy. Individuals would need to receive a doctor’s recommendation for the treatment of certain qualifying conditions, which include several specific ailments as well as terminal illnesses and chronic diseases where opioids are the standard of care. Among the public, medical marijuana legalization enjoys overwhelming bipartisan support in the state, with a 2024 poll finding that 93 percent of Democrats, 74 percent of Republicans and 84 percent of independents back the reform. The state Senate passed an earlier version of the legislation in 2022, but it stalled in the opposite body over a procedural hiccup. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — When senators began debating the medical marijuana legislation in 2024, the body adopted an amendment that clarifies the bill does not require landlords or people who control property to allow vaporization of cannabis products. As debate on the legislation continued, members clashed over whether the current version of the legislation contains major differences from an earlier iteration that the body passed in 2022. Certain lawmakers have also raised concerns that medical cannabis legalization would lead to broader reform to allow adult-use marijuana, that it could put pharmacists with roles in dispensing cannabis in jeopardy and that federal law could preempt the state’s program, among other worries. After Davis’s Senate-passed medical cannabis bill was blocked in the House in 2022, he tried another avenue for the reform proposal, but that similarly failed on procedural grounds. The lawmaker has called the stance of his own party, particularly as it concerns medical marijuana, “an intellectually lazy position that doesn’t even try to present medical facts as they currently exist.” Photo courtesy of Max Pixel. The post South Carolina GOP Governor Candidates Are Open To Signing Medical Marijuana Legalization Bill, They Say During Debate appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

WA officials: Federal marijuana rescheduling doesn’t apply here; Congressional report calls out FDA on hemp; NC psychedelics Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Before you dig into today’s cannabis news, I wanted you to know you can keep this resource free and published daily by subscribing to Marijuana Moment on Patreon. We’re a small independent publication diving deep into the cannabis world and rely on readers like you to keep going. Join us at https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Virginia Gov. Abigail Spanberger (D) and key lawmakers announced the details of a compromise on recreational marijuana sales legalization they plan to enact through budget legislation this month—a deal that came together after the governor vetoed a previous plan to pass the reform. The Congressional Research Service notes in a new report that the Food and Drug Administration has missed a deadline to publish lists of hemp-derived cannabinoids and to issue guidance on the term “container” with respect to hemp product THC serving sizes. The Washington State Liquor and Cannabis Board published guidance saying that federal marijuana rescheduling in its current form “does not appear to apply” to businesses in the state due to the fact that it doesn’t specifically license medical cannabis producers, processors or retailers. Bipartisan North Carolina lawmakers are calling on colleagues to pass legislation to fund research on the therapeutic value of substances like psilocybin, ibogaine and MDMA in treating military veterans, first responders, frontline healthcare personnel and survivors of domestic violence or sexual assault. / FEDERAL Homeland Security Secretary Markwayne Mullin, who owns a stake in a kratom company, pushed other Trump administration officials to downplay concerns about the plant. The Drug Enforcement Administration promoted an article about the dangers of using methamphetamine during the hot summer months. The House bill to continue the 280E tax penalty on marijuana businesses after rescheduling got one new cosponsor for a total of 12. / STATES Illinois Gov. JB Pritzker (D) tweeted, “Illinois is taking action to protect our children from misleading packaging and labeling. This landmark legislation closes the intoxicating hemp loophole while bolstering equity and oversight and expanding medical access.” Virginia’s Senate president pro tempore, when asked whether she could benefit from marijuana sales legalization legislation, said, “I only have a little CBD shop. I have not applied for a license. Matter of fact, I don’t even run the shop, I have other people who do. So maybe, maybe not.” A federal judge issued a temporary restraining order blocking enforcement of Ohio hemp THC product restriction rules. Massachusetts regulators published guidance about a moratorium on marijuana cultivator license applications. Vermont regulators published guidance about outdoor security for cannabis businesses. New York regulators cheered an appeals court’s move to vacate a preliminary injunction blocking enforcement action against unlicensed cannabis sales. The California Legislative Analyst’s Office published an annual report on tax exemptions for donations of medical cannabis products. The Nebraska Board of Parole is considering the case of a parolee who has been using cannabis gummies. Washington, D.C. officials shut down additional unlicensed cannabis retailers. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL New York City’s government-sanctioned safe drug consumption sites announced that staff have intervened in more than 2,000 overdoses with no fatalities since opening in late 2021. / INTERNATIONAL A Canadian lawmaker filed a bill to let doctors prescribe psilocybin and psilocin without needing approval from federal officials. / SCIENCE & HEALTH A review concluded that “cannabinoid-based therapies showed lower agitation and neuropsychiatric symptom scores than placebo in” Alzheimer’s disease. A study found that “subjective sleep quality improved in [chronic cluster headache] patients after psilocybin and showed some evidence of an association with measures of brain microstructure and water diffusivity.” / ADVOCACY, OPINION & ANALYSIS The Kentucky Democratic Party called out a Republican lawmaker over medical cannabis prosecution comments, tweeting, “Targeting the terminally ill shows an utter lack of humanity.” / BUSINESS High Tide Inc. reported quarterly revenue of C$179.3 million. Innovative Industrial Properties, Inc. declared a quarterly dividend of $7.60 per share. / CULTURE Wiz Khalifa’s cannabis brand is launching in the Australian medical cannabis market. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Virginia governor announces cannabis plan to pass this month (Newsletter: June 17, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

This is my first time i visit here and I found so many interesting stuff in your blog especially it's discussion, thank you. 도파민가라오케

Document went on your web page at the same time re-focusing only just to some extent submits. Excellent technique for so next, I'll be book-marking instantly catch any carry out springs up. 구구단쩜오

Cheap content, With thanks just for stating This approach skills. Wonderfully developed page, only if all of the the blogosphere obtainable the equivalent degree content and articles simply because, websites became a more desirable space. Delight continue! 구구단쩜오

Marijuana regulators in Washington say that the Trump administration’s move to reschedule cannabis on the federal level “does not appear to apply” to businesses in the state. The U.S. Department of Justice in April issued an order that immediately reclassified state-licensed medical cannabis, as well as marijuana products approved by the Food and Drug Administration (FDA) from Schedule I of the Controlled Substances Act (CSA) to Schedule III. A hearing scheduled for later this month will consider more comprehensively moving marijuana to Schedule III. “Washington does not license medical cannabis producers, processors, or retailers,” the state Liquor and Cannabis Board (LCB) said in guidance published on Tuesday. “Instead, Washington has a single recreational market and within that market producers/processors may manufacture [Department of Health]-compliant products, and certain retailers may sell DOH-compliant products to all adult patients and designated providers.” “Because of this, Washington’s cannabis licensees do not appear to qualify as ‘state medical marijuana licensee[s]’ and therefore may not be eligible to register under the Final Rule,” the agency said, referring to a Drug Enforcement Administration (DEA) registration process for state-legal marijuana businesses to take advantage of federal benefits that come with the reform. That said, LCB is “not taking a position to prevent licensees from applying for federal registration if they choose,” the guidance continues. “If any licensee does apply for federal registration, we would be interested in learning about their experience and any federal determination.” Nonetheless, “based on our analysis, federal rescheduling in its current form does not appear to apply to Washington’s cannabis licensees due to the statutory framework predominately regulating recreational cannabis,” LCB said. The agency did stress, however, that while it has consulted with the Cannabis Regulators Association, National Governors Association and industry stakeholders, its current view does not represent the formal opinion of Washington and “may not be our final interpretation as information is evolving and the determination may not rest with the state.” “We expect additional guidance from involved federal agencies, new or updated federal agency processes, and/or other federal proceedings,” it said, citing the upcoming administrative hearing and ongoing litigation challenging cannabis rescheduling. “The LCB recognizes there are many cannabis producers, processors, and retailers that actively engage in the production and sales of medical cannabis in Washington. These businesses may or may not have an opportunity to use the 280e tax deduction and additionally register with the DEA for a schedule III permit. The determination of the applicability of 280e and qualification for DEA schedule III permits is with the federal government and not with the state of Washington. It is possible that the state of Washington will ultimately not have any input into the determination as to whether its licensees meet the criteria for ‘state medical marijuana licensees,’ as DOJ may make that determination unilaterally. DOJ has the authority to reasonably interpret the meaning of the Final Rule, and a determination that Washington cannabis licensees do qualify as ‘state medical marijuana licensee[s].'” The U.S. Department of the Treasury and Internal Revenue Service (IRS) said they plan to issue new tax guidance for the marijuana industry following rescheduling. The reform will benefit state-licensed marijuana businesses by allowing them to take federal tax deductions they’re currently barred from under an IRS code known as 280E that doesn’t apply to Schedule III substances. In California, regulators recently adopted emergency rules changes for the state’s marijuana licensing process that are intended to make it easier for businesses to qualify for benefits in line with the Trump administration’s recent move to federally reschedule medical cannabis. The post Federal Marijuana Rescheduling ‘Does Not Appear To Apply’ To Washington Businesses, State Officials Say appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Bipartisan North Carolina lawmakers are stepping up the push for psychedelics reform legislation by asking colleagues to pass it as part of the budget. Several members of the Senate and House of Representatives spoke at a press conference on Tuesday in support of a bill to fund research on the therapeutic value of substances like psilocybin, ibogaine and MDMA in treating military veterans, first responders, frontline healthcare personnel and survivors of domestic violence or sexual assault. “This bill makes a real investment in mental health innovation, research and access to the people of our state,” Sen. Robert Brinson (R), lead sponsor of the Healing through Evidence-based Access to Lifesaving Care (HEAL) Act, said, noting that “momentum is building” for psychedelics reform at the federal and state levels. Rep. Allen Chesser (R) cited statistics about the large number of military veterans who die from suicide, saying that “if we keep doing what we’ve done, we’re going to keep losing the veterans that we’ve sworn to protect.” “This is not a radical liberal idea, and it does not belong to one party or the other,” he said of psychedelics reform. “We stand here, representatives from both sides of the aisle, from both chambers, working together, because good policy crosses borders.” “We’re here today because there is a new option… They’ve had phenomenal results,” Chesser said of psychedelics. “These aren’t fringe ideas. They are on the path to becoming approved medicines.” Sen. Sophia Chitlik (D) said that “study after study…have shown that psychedelics can yield durable, measurable results for treating trauma and depression.” “Veterans give everything to defend our country, and some of the most severe wounds that they come back with are invisible to most of us, but they are not invisible to their loved ones,” she said. “Today I’m proud to say that these wounds are no longer invisible to their legislators.” Chitlik and other lawmakers filed a separate bill last year to authorize the creation of a new state psychedelics task force to study and issue recommendations on providing access to the alternative therapies to address serious mental health conditions. In 2023, a North Carolina House committee approved a separate bill to create a $5 million grant program to support research into the therapeutic potential of psilocybin and MDMA and to create a Breakthrough Therapies Research Advisory Board to oversee the effort. The measure was not ultimately enacted, however. Rep. Eric Ager (D) said that PTSD “is rampant across the veteran community.” “Clearly, what we’re currently doing isn’t working. It’s time to take a close look at the alternatives,” he said. “This bill is the very beginning of that, and I look forward to working with my colleagues. I really hope we get it into the budget and can get it passed.” If the legislation is enacted, a new Breakthrough Therapies Research Grant Fund would be established under the Department of Health and Human Services to award competitive grants for research on drugs designated as “breakthrough therapies” by the federal Food and Drug Administration (FDA). The money would support three-year studies on the benefits of psychedelics for populations that are disproportionately impacted by trauma, with the legislation specifying that “the research study involving psilocybin shall be concentrated on the treatment of anxiety disorder, depressive disorder, or both.” S1018 would also create a new Breakthrough Therapies Task Force charged with studying psychedelics’ potential and barriers to access, reviewing research grant applications and recommending licensing and insurance requirements for therapeutic use. The body would additional be charged with considering “legal and regulatory pathways to the legalization of psychedelic medicines in the State and the potential effects of the medicines on public health.” The legislation, which cites a psychedelics executive order that President Donald Trump signed in April, seeks to appropriate $5.4 million in funding to support the research grants and overall effort. Brinson, the lead sponsor, said at a separate event last year that North Carolina has opportunity to “lead the nation” in expanding access to psychedelic medicine for military veterans suffering from major mental health conditions. Advocates called on lawmakers to pass the legislation. “At a time when so many individuals and families are struggling with mental health challenges that traditional treatments have failed to address, we believe it is crucial to expand access to therapies that are showing promise,” Gina Giorgio, founder of Carolinas for Care, said in a press release. “Our work brings together lived experience, clinical expertise, and community advocacy to ensure that care is informed by science and delivered with compassion.” Logan Davidson, legislative director for Veterans Exploring Treatment Solutions (VETS), said that “veterans across the Carolinas deserve access to treatments that actually work.” “VETS has seen firsthand how psychedelic-assisted therapies can restore what PTSD and traumatic brain injury have taken from those who served—but too many of our veterans are still waiting,” he said. “The HEAL Act gives North Carolina the tools to accelerate the research that can change that, and we’re proud to stand with Carolinas for Care in making that case to the General Assembly.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, North Carolina’s Senate president pro tempore recently said that lawmakers will take a more serious look at legalizing medical marijuana following the Trump administration’s move to reschedule cannabis at the federal level. The North Carolina Senate has passed medical cannabis bills in a number of past sessions that have later stalled out in the House of Representatives. The Senate leader’s comments came weeks after a governor-appointed cannabis commission in North Carolina issued a report recommending that the state move away from a criminalization-based approach to the plant and toward a system of “robust” regulations that provide for adults’ legal access to THC products. The North Carolina Advisory Council on Cannabis, which Gov. Josh Stein (D) convened last year, says in the new document approved in April that the current “absence of regulation for North Carolina’s intoxicating cannabis market raises numerous concerns,” noting that hemp products are readily available yet largely unregulated and that marijuana remains prohibited altogether in the state, even for medical use. Stein, for his part, thanked the group for its “expertise, hard work, and thoughtful deliberation” in a press release and reiterated his support for legalizing marijuana. “Last year, I charged this group with developing a comprehensive solution to the unregulated sale of cannabis that is grounded in public health and public safety, with a special focus on keeping young people safe,” the governor said. “This report provides the General Assembly with guidance and makes clear that a well-regulated market, including both oversight and enforcement authority, is a safer market for our state.” The interim report recommends that rather than construct separate frameworks for hemp and marijuana, the state should enact molecule-based regulation focused on THC itself, saying that “the plant source is irrelevant and should not drive different treatment when the intoxicating compound is the same.” It also suggests that when choosing how to regulate THC and cannabis, North Carolina should enact “an adult access market with protections for medical consumers.” The panel, however, “does not view a medical-only program as an effective interim step or compromise solution,” and the state should proceed to adult-use access immediately while considering the “availability of medical-consumer protections” as “an important component of a broader regulatory structure.” During his time as the state’s attorney general, Stein led a separate task force under then-Gov. Roy Cooper (D) that examined racial injustice issues and ultimately recommended decriminalizing marijuana and studying broader legalization in response to racially disparate enforcement trends. Meanwhile, a tribe in North Carolina, the Eastern Band of Cherokee Indians, launched the state’s first marijuana dispensary in 2024—despite the protests of certain Republican congressional lawmakers. Lawmakers have also filed legislation this session to allow North Carolina voters to decide whether to legalize marijuana for personal or medical use at the ballot box this November. Photo courtesy of Mark Groeneveld. The post Bipartisan North Carolina Lawmakers Say Psychedelic Research Bill Can Help Military Veterans appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Virginia’s governor and key lawmakers have announced the details of a plan to legalize recreational marijuana sales through budget legislation this month following the veto of a previous proposal to enact the reform. Gov. Abigail Spanberger (D) on Tuesday appeared at a press conference alongside legislators who sponsored bills she rejected earlier this year to unveil a new compromise approach that they have agreed on. “We have agreed to a proposal that will create a safe, legal and well-regulated cannabis marketplace here in the commonwealth of Virginia—with recreational sales beginning on July 1, 2027,” the governor said. “We will do it in a way that protects consumers, tamps down with the goal of eliminating the illicit market with clear enforcement and regulatory authority and creates a more competitive market for small businesses and farmers.” “This is what good governing and collaboration looks like—bringing people together, listening carefully and focusing on solutions that are practical, enforceable and in the best interest of Virginians,” she said. “In the end, we all wanted to deliver a marketplace that the commonwealth could implement effectively for the long-term. We have always had this same end goal—an end goal that has been years in the making—so I am proud to stand alongside these dedicated legislators and to be working alongside alongside them to deliver a marketplace built to last.” Sen. Lashrecse Aird (D), the lead sponsor of the Senate version of the previous cannabis measure Spanberger vetoed, said she believes the newly negotiated deal “strikes the right balance.” “Virginians deserve to know that they are buying items that are accurately labeled, properly tested and sold in a secure environment,” she said. “This framework gives us a real path to move demand out of the illicit market and into a regulated system built around safety, accountability and consumer protection.” Del. Paul Krizek (D), who sponsored the House of Delegates version of the earlier marijuana legislation, said the goal is to “create a cannabis market that is responsible” and that gives small businesses “a real chance to succeed.” “For decades, cannabis enforcement created real consequences for individuals, families and documented disproportionate impact to communities,” he said. “A legal marketplace should not lock those same communities out of the economic opportunity created by reform.” “Part of the responsible legalization that we have before you today is recognizing that those past cannabis policies did not affect every community equally as we move into a legal marketplace,” Krizek said. “We have an obligation to make sure opportunity is not limited only to those who already have access to capital and political connections.” The new plan differs significantly in several ways from the earlier legislation that lawmakers passed earlier this year and that the governor vetoed. For example, it sets the launch date for recreational marijuana sales at July 1, 2027, which is what Spanberger proposed in contrast to the January 1 date in what lawmakers had passed. It also sets the legal public marijuana possession and per-transaction purchase limit at 2 ounces, an increase from the current legal limit of one ounce. The legislation lawmakers passed earlier this year would have allowed adults to possess up to 2.5 ounces. The bill also cedes to Spanberger on language to increase a marijuana excise tax from 6 percent to 8 percent after two years of legal sales. By way of compromise, the new agreement would make public consumption of marijuana punishable by a civil penalty of $250—a significant increase from the $25 in current law but less harsh than the class 4 criminal misdemeanor the governor sought in her proposed changes to the previous bill. The penalty increase would not take effect until July 1 of next year, however, raising the possibility that lawmakers could pass legislation next session to rescind it. Lawmakers passed the initial cannabis sales bills in March, but the governor then suggested changes to the legalization proposal—including delaying the start date for sales by six months, increasing taxes and instituting new criminal penalties for cannabis consumers. The legislature in April declined to take up the amendments during a one-day reconvened session, however, effectively rejecting them. Spanberger then issued a veto. Spanberger said last week that she was having “really productive” and “incredible” conversations with lawmakers about crafting a compromise approach to legalizing adult-use cannabis sales, and Marijuana Moment previously reported on the ongoing talks. Following Spanberger’s veto, top lawmakers have been openly discussing the possibility of including provisions to legalize adult-use cannabis sales in still-outstanding budget legislation that they are due to pass by July 1. The effort to keep the issue alive was a topic of discussion at the first meeting of the legislature’s Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market since the governor’s move to kill the previous proposal to regulate adult-use marijuana sales. The governor, meanwhile, has tried publicly explain her veto—including by saying it is her view that “taking a little bit longer” to launch the market is not something she sees as “negative” because it is more important to get the details right than to do it fast. A recent survey found that bipartisan majorities of Virginia voters wanted Spanberger to sign the cannabis legislation into law, and that they specifically disagreed with her desire to slow the launch timeline for legal sales. The governor recently acknowledged in a separate interview that “a lot of people are not pleased” with her veto of the cannabis legislation. “Friends and family are displeased as well,” she said. Spanberger has repeatedly responded to criticism of her cannabis amendments from the bill sponsors and advocates by saying the suggested changes came after she spoke to the leaders of other states that have already implemented adult-use marijuana markets. A spokesperson for Spanberger declined to name any other governors she talked to about cannabis in response to a question from Marijuana Moment, however. The governor separately recently sought to explain her veto in an earlier interview, reiterating that she supports launching a legal cannabis market but worried about what she called a “rushed timeline” and “far more stores across Virginia” than she thinks are appropriate. Prior to vetoing the cannabis commerce bill, the governor did sign separate legislation to provide resentencing relief for people with past cannabis convictions. I am excited to announce a compromise proposal for a safe, legal, and well-regulated cannabis marketplace here in Virginia. We will do it in a way that protects consumers, tamps down on the illicit market with clear enforcement and regulatory authority, and keep our kids safe… — Governor Abigail Spanberger (@GovernorVA) June 16, 2026 Personal marijuana possession and home cultivation of marijuana has been legal in Virginia since 2021, but then-Gov. Glenn Youngkin (R) twice vetoed bills to provide consumers with a way to legally purchase regulated adult-use cannabis. Aird and Krizek, the sponsors of the legalization bills, had urged colleagues to vote against the governor’s amendments—even if that meant risking a veto from Spanberger when the legislation returned to her desk. Here are the key details of the new cannabis plan and how it compares to legislation that Spanberger vetoed—SB 542 and HB 642—as well as her previously proposed amendments to those measures: Adults would be able to purchase up to 2 ounces of marijuana in a single transaction, or up to an equivalent amount of other cannabis products as determined by regulators. That would represent an increase from the limit in current law of 1 ounce. Lawmakers previously proposed setting the amount at 2.5 ounces and the governor only wanted 2 ounces. Legal sales could begin on July 1, 2027. Lawmakers previously set the date for January 1, 2027, but the governor wanted it pushed back to July 1. There would be an excise tax of 6 percent on cannabis sales as well as a 5.3 percent retail sales and use tax, and municipalities would be allowed to set an additional local tax of up to 3.5 percent. Starting on July 1, 2029, the state excise tax would increase to 8 percent, in line with the governor’s previously proposed amendments. Revenue would be distributed to the Cannabis Equity Reinvestment Fund, early childhood education, the Department of Behavioral & Developmental Health Services and public health initiatives. The earlier measure passed by lawmakers would have allocated specific percentages to each, but the new language doesn’t specify what portion of revenue will go to each program. The governor, in her amendments, wanted to put all revenue into the general fund while earmarking it “for purposes such as early childhood education, behavioral health, public health awareness, prevention, treatment, and recovery services, workforce development, reentry, indigent criminal defense, and targeted reinvestment in historically disadvantaged communities.” Her amendment also sought to eliminate support for the Cannabis Equity Reinvestment Fund. The Virginia Cannabis Control Authority would oversee licensing and regulation of the new industry, and will also take on oversight of hemp, which is currently under the Department of Agriculture and Consumer Services. The body would be governed by a five-member board of directors appointed by the governor, whereas the bill previously passed by lawmakers contemplated a seven-member body with four appointed by the governor, two appointed by the speaker of the House and one appointed by the Senate Rules Committee. The definition of what constitutes a legal hemp product would be narrowed by removing a provision from current law that allows those containing more than 2 milligrams of total THC per package if they also have a ratio of CBD to THC that is 25:1 or more. Up to 350 retail marijuana stores would be allowed to be licensed to operate across the state, the same number that lawmakers had approved and greater than the 200 the governor had proposed. Local governments would not be able to out of allowing marijuana businesses to operate in their area. Delivery services would be allowed. Serving sizes would be capped at 10 milligrams THC, with no more than 100 mg THC per package. Public use of marijuana would be a civil violation punishable by a $250 fine. That is ten times more than the $25 fine under current law, but less harsh than than the class 4 criminal misdemeanor crime the governor had proposed. Possession of cannabis by people under the age of 21 would be punishable by a $25 fine and mandatory participation in a substance abuse treatment or education program or both. The governor had suggested treating underage possession as a class 1 misdemeanor, punishable with a mandatory minimum fine of $500 or 50 hours of community service, as well as the suspension of drivers licenses for at least six months. Existing medical cannabis operators could enter the adult-use market if they pay a $10 million licensing conversion fee. Cannabis businesses would have to establish labor peace agreements with workers. A legislative commission would be directed to study adding on-site consumption licenses and microbusiness cannabis event permits that would allow licensees to conduct sales at venues like farmers markets or pop-up locations. That provision was also included in the earlier legislation lawmakers passed but was suggested for deletion by the governor. Marijuana reform advocates cheered the fact that a legal sales deal is coming together, but they expressed concerns about some of the penalty increases in the bill. “This compromise represents a meaningful step toward bringing Virginia’s cannabis laws in line with public opinion and moving the commonwealth closer to a marketplace that consumers have long demanded,” JM Pedini, development director for the advocacy group NORML and executive director for Virginia NORML, said. “Although NORML has deep concerns about provisions in the bill to increase the civil penalty for public cannabis consumption, we are encouraged by other areas of broader agreement. This bill establishes a consumer-friendly regulated marketplace, improves public safety and provides clear rules for everyone involved.” Meanwhile, the governor signed several other reform bills this session—including measures to protect the parental rights of marijuana consumers and allow patients to access medical cannabis in hospitals. The post Virginia Governor And Lawmakers Unveil Newly Negotiated Bill To Legalize Marijuana Sales That’s Expected To Pass This Month appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Thanks for the blog loaded with so many information. Stopping by your blog helped me to get what I was looking for. data keluaran sgp

I would like to say that this blog really convinced me to do it! Thanks, very good post. pengeluaran togel singapura terbaru

Congressional researchers are noting that the Food and Drug Administration (FDA) has missed a legal deadline to publish a list of known cannabinoids as federal hemp laws are set to change later this year in a way that stakeholders argue will upend the existing market. As part of appropriations legislation that President Donald Trump signed last year, many hemp products that were legalized during his first term in office under the 2018 Farm Bill will be prohibited once again starting in November. The spending measure included separate provisions, however, directing FDA and other relevant agencies to study the cannabinoid marketplace and develop lists of cannabis components. After the bill was signed, FDA was given 90 days to publish 1) a list of “all cannabinoids known to FDA to be capable of being naturally produced” by cannabis 2) a list of “all tetrahydrocannabinol class cannabinoids known to the agency to be naturally occurring in the plant” and 3) a list of “all other know cannabinoids with similar effects to, or marketed to have similar effects to, tetrahyrocannabinol class cannabinoids.” Further, the agency was tasked with providing “additional information and specificity about the term ‘container’” with respect to hemp product THC serving sizes. In the bill, the term is defined as “the innermost wrapping, packaging, or vessel in direct contact with a final hemp-derived cannabinoid product in which the final hemp-derived cannabinoid product is enclosed for retail sale to consumers, such as a jar, bottle, bag, box, packet, can, carton, or cartridge.” The lists and information was due months ago, on February 10, but FDA did not follow through by the deadline—and still hasn’t published the required information. Now, the Congressional Research Service (CRS) is noting in a report published late last month that the law “requires FDA to consult with relevant federal agencies and publish [the guidance] within 90 days of enactment (which, as of May 2026, has not been published).” Marijuana Moment sent several requests to FDA for an update on its plans to publish the required guidance and any reaction to CRS’s report, but representatives did not reply. A spokesperson for the U.S. Department of Health and Human Services (HHS), of which FDA is a component, told Marijuana Moment earlier this year that it was the agency’s intention to provide the lists in time and that they would be published in the Federal Register. However, that’s yet to materialize—and officials did not provide clarification when asked for an update. Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that Trump signed during his first term in office. But late last year, the president signed new spending legislation containing provisions that will redefine hemp to make it so only products with 0.4 milligrams of total THC per container will remain legal after November 12. Lawmakers from both parties have filed several bills and amendments to delay, alter or cancel the planned recriminalization of hemp THC products, but none of those proposals have gained traction with congressional leadership. The new CRS report, meanwhile, said that as the U.S. Department of Agriculture (USDA) reworks hemp regulations in line with the new definition of legal products, “Congress may consider the potential effects on farmers, law enforcement, and consumers.” “For example, Congress may conduct oversight of USDA implementation of the definitional changes in the department’s Domestic Hemp Production Program and the impact of the definitional changes on hemp producers,” it says. The White House this month issued a statement saying the Trump administration wants Congress to take action to amend the law in order to keep hemp-derived full-spectrum CBD products legal. In April, the president himself urged congressional lawmakers to again redefine hemp to avoid recriminalization of full-spectrum CBD products. “I am calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on, and that help them, while preserving Congress’s intent to restrict the sale of products that pose Health risks,” Trump said in a Truth Social post on the same day his administration announced it is moving forward with rescheduling marijuana. “We must get this done RIGHT and FAST, especially for those who saw that CBD helps them,” he said. “Plus, I am told it will also help our GREAT FARMERS, who we love, and will always be there for.” Photo courtesy of Kimzy Nanney. The post Congressional Researchers Call Out FDA For Missing Deadline To Publish Cannabinoid List And Define Hemp ‘Containers’ appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

New congressional bill to keep hemp THC drinks legal; CA GOP senator: Repeal marijuana legalization; Study: Sleep & cannabis about more than THC Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there. Support our work at https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW The National Institute of Standards and Technology added dozens of marijuana components to an official government library of compounds—providing “reference spectra needed to identify rare plant variants, degradation artifacts and minor homologs that are becoming increasingly relevant in modern cannabis testing.” Rep. Beth Van Duyne (R-TX) is circulating a draft bill that would keep hemp THC beverages federally legal, with new regulations—creating a carve-out from the broad recriminalization of hemp products that is set to take effect in November. A California Republican senator said it’s time to have a “serious discussion” about putting a measure on the ballot to potentially “reverse” marijuana legalization—also raising concerns about President Donald Trump’s move to reschedule cannabis at the federal level. Andrea Efre of the University of South Florida College of Nursing authored a Marijuana Moment op-ed detailing a new study she helped conduct on cannabis and sleep—finding that “the strongest evidence for improving sleep was associated with cannabidiol (CBD), cannabinol (CBN) and combinations of the two—but not primarily THC.” The Rhode Island Senate confirmed a new chair of the Cannabis Control Commission on the last day of the legislative session. / FEDERAL White House Office of National Drug Control Policy Director Sara Carter sent an open letter about what she called the World Anti-Doping Agency’s “unjustifiable exclusion” of the U.S. from an upcoming executive committee meeting. The Drug Enforcement Administration Museum sent a newsletter with various updates. / STATES A Pennsylvania Republican senator called out the Senate minority leader over the defeat of his cannabis regulatory bill, tweeting, “Chinese weed in gas stations is Pennsylvania’s teen cannabis policy. Next kid that dies is on you Jay. You asked for the ‘No vote.'” California regulators are moving to change rules on cannabis plant tagging. Washington State regulators sent a notice about an increase in cannabis license fees taking effect on July 1. Massachusetts’s new top cannabis regulator discussed his priorities in the role. Virginia regulators discussed the implications of federal marijuana rescheduling. Oregon regulators posted a summary of listening sessions about the psilocybin services program. The Nevada Cannabis Compliance Board will meet on Thursday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL The mayor of Forest Lake, Minnesota opened a marijuana dispensary. / INTERNATIONAL Ontario, Canada officials ordered SNDL Inc. to sell its network of several dozen cannabis stores in the province or risk having its licenses revoked. / SCIENCE & HEALTH A study of patients with spinal cord injury found that “CBD significantly reduced the self-reported intensity of neuropathic pain and was generally well-tolerated.” A study of rats found that “CBD may support opioid-sparing pain management strategies.” / ADVOCACY, OPINION & ANALYSIS The Kentucky Democratic Party criticized a Republican lawmaker’s comments about prosecuting people who comply with Gov. Andy Beshear’s (D) executive order to expand medical cannabis access. The Cannabis Regulators Association elected new executive board members. / BUSINESS Vireo Growth Inc. is acquiring C21 Investments Inc. High Tide Inc. is acquiring J. Supply Holdings Inc., operating as Northern Helm. Canopy Growth Corporation reported quarterly net revenue of C$71.2 million and a net loss from continuing operations of C$154.7 million. FLUENT Corp.’s interim CEO stepped down. / CULTURE Former basketball player Shaquille O’Neal said he “never really liked the smell” of marijuana. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Chris Wallis // Side Pocket Images. The post Feds add new cannabis components to research library (Newsletter: June 16, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

This particular is usually apparently essential and moreover outstanding truth along with for sure fair-minded and moreover admittedly useful My business is looking to find in advance designed for this specific useful stuffs… แทงบอลโลก

This is such a great resource that you are providing and you give it away for free. I love seeing blog that understand the value of providing a quality resource for free. แทงบอล